Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

MGC Pharmaceuticals: analyst reviews prospects after recent results and funding

MGC Pharmaceuticals: analyst reviews prospects after recent results and funding

Proactive Research analyst John Savin presents his analysis on MGC Pharmaceuticals.

The core marketed products are a food supplement, ArtemiC, to help overcome COVID-19 infection and medicinal cannabis products sold in Australia, UK and Ireland.

He also talk about the new medical ZAM app: a real-time data collection smartphone app with proprietary artificial intelligence (AI) algorithms.

Click here to read the report

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK